Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Takeda Pharmaceuticals Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (115)
Cancellation by sponsor (61)
Prescription medicine registration (15)
Australian public assessment report (AusPar) (11)
Designation or determination (5)
Prescription medicine decision summary (4)
Prescription medicine evaluation (1)

Date

2026 (7)
2025 (4)
2024 (31)
2023 (7)
2022 (14)
2021 (14)
2020 (13)
2019 (17)
2018 (6)
2017 (34)
2016 (5)
2015 (5)
2014 (14)
2013 (11)
2012 (3)
2010 (1)
2009 (2)
2008 (8)
2007 (2)
2006 (1)
2005 (9)
2002 (1)
2000 (2)
1999 (1)

Search

Sponsor content

212 result(s) found, displaying 171 to 180

VYVANSE lisdexamfetamine dimesilate 50mg capsule bottle (199226)

22 July 2013

ARTG

Australian Register of Therapeutic Goods (ARTG) information for VYVANSE lisdexamfetamine dimesilate 50mg capsule bottle.
VYVANSE lisdexamfetamine dimesilate 30mg capsule bottle (199227)

22 July 2013

ARTG

Australian Register of Therapeutic Goods (ARTG) information for VYVANSE lisdexamfetamine dimesilate 30mg capsule bottle.
VYVANSE lisdexamfetamine dimesilate 70mg capsule bottle (199228)

22 July 2013

ARTG

Australian Register of Therapeutic Goods (ARTG) information for VYVANSE lisdexamfetamine dimesilate 70mg capsule bottle.
KIOVIG normal immunoglobulin (human) 30g/300mL solution for injection vial (198488)

29 May 2013

ARTG

Australian Register of Therapeutic Goods (ARTG) information for KIOVIG normal immunoglobulin (human) 30g/300mL solution for injection vial.
CINRYZE C1 esterase inhibitor 500 units powder for solution for injection vial with diluent vial (177513)

5 April 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CINRYZE C1 esterase inhibitor 500 units powder for solution for injection vial with diluent vial.
FEIBA-NF factor VIII inhibitor bypassing fraction 2500U powder for injection vial with diluent vial (172236)

30 March 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for FEIBA-NF factor VIII inhibitor bypassing fraction 2500U powder for injection vial with diluent vial.
VPRIV velaglucerase alfa (ghu) 400 Units powder for solution for infusion, glass vial (180965)

29 February 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for VPRIV velaglucerase alfa (ghu) 400 Units powder for solution for infusion, glass vial.
PANTOLOC HEARTBURN RELIEF pantoprazole (as sodium sesquihydrate) 20mg tablet blister pack Cancelled under s30(1)(c) of the Act

2 October 2015

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
PANTOZOL HEARTBURN RELIEF pantoprazole (as sodium sesquihydrate) 20mg tablet blister pack Cancelled under s30(1)(c) of the Act

2 October 2015

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd
PANTOMAC HEARTBURN RELIEF pantoprazole (as sodium sesquihydrate) 20mg tablet blister pack Cancelled under s30(1)(c) of the Act

2 October 2015

Cancellation by sponsor

Requested by Takeda Pharmaceuticals Australia Pty Ltd

Pages

First page
Previous page
…
Page 14
Page 15
Page 16
Page 17
Current page 18
Page 19
Page 20
Page 21
Page 22
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.